MedTrace Logo

Radio Frequency Ablation (RFA STUDY )

NCT02631278 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-12-16

No results posted yet for this study

Summary

The aim of this study is to investigate the safety and feasibility of a radiofrequency (RF) system employing RFITT (CelonProSurge) probes for the ablative treatment of uterine fibroids.

Conditions

  • Uterine Myoma

Interventions

DEVICE

Intraoperative radiofrequency ablation

Intra-operative Radiofrequency ablation will be carried out and followed by surgical removal of the treated leiomyoma.

Sponsors & Collaborators

  • Olympus Winter & Ibe

    collaborator UNKNOWN

  • Catholic University of the Sacred Heart

    lead OTHER

Principal Investigators

  • Giovanni Scambia, MD · Catholic University of Sacred Heart - Rome

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02631278 on ClinicalTrials.gov